Results for tag: "Kanuma"

Kanuma is a drug used to treat lysosomal acid lipase deficiency (LAL-D), a rare metabolic disorder. It is a recombinant form of human lysosomal acid lipase, which is a critical enzyme for breaking down lipids in the body. Kanuma is the only approved therapy for LAL-D, and is available in both oral and intravenous formulations. It is used to reduce the accumulation of lipids in the liver, spleen, and other organs, and to improve the patient's overall health. Kanuma is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions, such as diabetes, obesity, and thyroid disorders. These drugs are used to regulate hormones, enzymes, and other substances in the body, and to improve the patient's overall health. Companies in the Kanuma market include Alexion Pharmaceuticals, Pfizer, and Sanofi. Show Less Read more